Our Focus Areas
The Cancer Research and Life Foundation specializes in developing and providing access to innovative treatments for the most challenging cancers. Our research focuses on non-toxic, targeted therapies that address cancer at the cellular level, offering hope to patients with advanced diseases.
BLOOD CANCER:
Epigenetic Therapy
Blood cancers, including leukemia, lymphoma, and myeloma, affect the blood, bone marrow, and lymphatic system. Our foundation supports research into epigenetic therapies—innovative treatments that modify gene expression without altering DNA sequences.
Why Epigenetic Therapy Matters: Traditional treatments for blood cancers often involve aggressive chemotherapy with significant side effects. Epigenetic therapies offer a more targeted approach by reversing abnormal gene expression patterns that drive cancer growth, potentially providing effective treatment with fewer toxic effects.
What We're Researching:
-
DNA methylation inhibitors
-
Histone modification therapies
-
Combination approaches with conventional treatments
-
Non-toxic alternatives to standard chemotherapy
Patient Impact: Epigenetic therapies can improve treatment response while reducing debilitating side effects, enhancing quality of life for patients with blood cancers.
SOLID TUMORS:
Comprehensive Treatment Approach
Solid tumors—cancers that form in organs and tissues such as breast, lung, colon, prostate, and pancreas—account for the majority of cancer diagnoses. Our foundation supports research into innovative therapies that target solid tumors through multiple mechanisms, addressing both primary tumors and metastatic disease.
Our Approach: Rather than relying solely on traditional surgery, radiation, and chemotherapy, we investigate complementary and integrative approaches that can enhance treatment effectiveness while reducing side effects.
search Focus:
-
Cancer stem cell targeting therapies
-
Immune system modulation
-
Metabolic interventions
-
Combination therapies that improve outcomes
-
Non-toxic treatment options for advanced disease
Treatment Goals: Our research aims to improve patient response to treatment, extend survival, and enhance quality of life for patients with solid tumor cancers at all stages—from newly diagnosed to advanced metastatic disease.
Patient Support: We provide access to clinical trials and innovative treatment protocols for patients with solid tumors who have limited options through conventional oncology.
Glioblastoma Multiforme
GLIOBLASTOMA MULTIFORME (GBM), A TYPE OF CENTRAL NERVOUS SYSTEM CANCER, IS THE MOST COMMON AND MOST AGGRESSIVE FORM OF PRIMARY BRAIN CANCER, ACCOUNTING FOR 54% OF NEW GLIOMAS AND 45% OF PRIMARY MALIGNANT TUMORS.
: The Cancer Research Life Foundation supports the research and development of novel therapies that can disrupt the current standard of care model in oncology. Throughout history, several groundbreaking discoveries have transformed cancer treatment—from the accidental discovery of chemotherapy during World War II to today's cutting-edge cancer stem cell research. We are committed to continuing this legacy of innovation by investing in the most promising therapeutic approaches.